Vaccine Bioproduction: An Industry In The Spotlight

The global crisis related to SARS-CoV-2 infections that began in late 2019 placed the bioprocessing industry in the spotlight due to the key role it plays in the development and manufacture of safe and effective vaccines. The industry has historically contributed to (and continues to contribute to) the improvement of global health: innovating new technologies, optimizing workflows, strengthening vaccine platforms, and moving to late-stage clinical trials at record speed. Upon vaccine approval, the pressure falls on manufacturers to quickly produce the vaccine in unprecedented volumes, creating the challenge of sourcing critical process materials from reliable suppliers. In this paper learn about the challenges of sourcing critical process materials from reliable suppliers, and how consistency and collaboration are required to ensure a reliable supply of bioprocess materials.